Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide | Zendy

François Montastruc | Zendy; Rui Nie | Zendy; Simone Y. Loo | Zendy; Soham Rej | Zendy; Sophie Dell’Aniello | Zendy; Joëlle Micallef | Zendy; Samy Suissa | Zendy; Christel Renoux | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide

Author(s) -

François Montastruc,

Rui Nie,

Simone Y. Loo,

Soham Rej,

Sophie Dell’Aniello,

Joëlle Micallef,

Samy Suissa,

Christel Renoux

Publication year - 2019

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2018.4149

Subject(s) - aripiprazole , medicine , antipsychotic , psychiatry , cohort , population , hazard ratio , pharmacoepidemiology , schizophrenia (object oriented programming) , medical prescription , pharmacology , confidence interval , environmental health

Some reports have raised concerns regarding a potential psychiatric worsening associated with first-time use of aripiprazole in patients already treated with other antipsychotic medications. Whether aripiprazole use, particularly in the long term, increases the risk for serious psychiatric events is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research